Click Here to
Subscribe
Breaking
News, Updates,
& More
Stay Up
to Date

Supportive Care

Bone metastases are exceedingly common among patients with cancer and can significantly affect quality of life. Approximately 65% to 75% of patients with advanced breast or prostate cancer have bone metastases, which can lead to devastating complications...
This section provides a quick update of symptomatic conditions in oncology and their management. Readers are invited to submit brief updates following the guidelines at www.JHOPonline.com.
This section provides a quick update of symptomatic conditions in oncology and their management.
Delaying medication processing is common, especially when it comes to oral cancer therapies. Oncologists at 3 oncology clinics looked at such barriers and the potential impact on patient outcomes.
This section provides a quick update of symptomatic conditions in oncology and their management. Readers are invited to submit brief updates following the guidelines at http://www.JHOPonline.com.
Sonia Amin Thomas, PharmD, discusses the clinical significance of her Symptom Management Overview, “Management of Hypercalcemia of Malignancy.”
Hypercalcemia is defined as a condition in which the serum calcium level is >10.5 mg/dL (the upper limit of normal) or the ionized calcium level exceeds 5.6 mg/dL. The consequences of abnormally high serum calcium can range from asymptomatic to life-threatening.
Opioid-induced constipation (OIC) is a common distressing symptom in patients with cancer who are taking opioids.
This section provides a quick update of symptomatic conditions in oncology and their management. Readers are invited to submit brief updates following the guidelines provided within.
Cancer in women ages 15 to 19 years is relatively rare, but when it occurs, menstruation can result in clinically significant complications. During the care of hematologic malignancies, heavy menstrual bleeding in this patient population is commonly correlated with thrombocytopenia. The effects of chemotherapy, radiation, or bone marrow transplantation are also potential secondary causes of therapy-induced thrombocytopenia, leading to excessive menstrual bleeding.
Page 1 of 3
Results 1 - 10 of 28